Brendan T. Griffin
Brendan T. Griffin
School of Pharmacy, University College Cork, Ireland
Verified email at - Homepage
Cited by
Cited by
Biopharmaceutical challenges associated with drugs with low aqueous solubility—the potential impact of lipid-based formulations
CM O'driscoll, BT Griffin
Advanced drug delivery reviews 60 (6), 617-624, 2008
Interactions between antidepressants and P‐glycoprotein at the blood–brain barrier: clinical significance of in vitro and in vivo findings
FE O'Brien, TG Dinan, BT Griffin, JF Cryan
British journal of pharmacology 165 (2), 289-312, 2012
Lipid-based nanocarriers for oral peptide delivery
Z Niu, I Conejos-Sánchez, BT Griffin, CM O’Driscoll, MJ Alonso
Advanced drug delivery reviews 106, 337-354, 2016
Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate
BT Griffin, M Kuentz, M Vertzoni, ES Kostewicz, Y Fei, W Faisal, C Stillhart, ...
European Journal of Pharmaceutics and Biopharmaceutics 86 (3), 427-437, 2014
From belly to brain: targeting the ghrelin receptor in appetite and food intake regulation
K Howick, BT Griffin, JF Cryan, H Schellekens
International journal of molecular sciences 18 (2), 273, 2017
Lactococcus lactis as a cell factory for delivery of therapeutic proteins
M Bahey-El-Din, CGM Gahan, BT Griffin
Current gene therapy 10 (1), 34-45, 2010
A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid‐based formulations in the anaesthetised rat model
BT Griffin, CM O'driscoll
Journal of pharmacy and pharmacology 58 (7), 917-925, 2006
Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8+ T cells against Listeria monocytogenes in the murine infection model
M Bahey-El-Din, PG Casey, BT Griffin, CGM Gahan
Vaccine 26 (41), 5304-5314, 2008
Focus: microbiome: the impact of the gut microbiota on drug metabolism and clinical outcome
EF Enright, CGM Gahan, SA Joyce, BT Griffin
The Yale journal of biology and medicine 89 (3), 375, 2016
A novel lipid-based solid dispersion for enhancing oral bioavailability of Lycopene – In vivo evaluation using a pig model
W Faisal, T Ruane-O’Hora, CM O’Driscoll, BT Griffin
International journal of pharmaceutics 453 (2), 307-314, 2013
Pharmacotherapy for neonatal seizures: current knowledge and future perspectives
MD Donovan, BT Griffin, L Kharoshankaya, JF Cryan, GB Boylan
Drugs 76 (6), 647-661, 2016
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability
BMDC Godinho, JR Ogier, A Quinlan, R Darcy, BT Griffin, JF Cryan, ...
International journal of pharmaceutics 473 (1-2), 105-112, 2014
Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs
BT Griffin, J Guo, E Presas, MD Donovan, MJ Alonso, CM O'Driscoll
Advanced drug delivery reviews 106, 367-380, 2016
Inhibition of P‐glycoprotein enhances transport of imipramine across the blood–brain barrier: microdialysis studies in conscious freely moving rats
FE O'Brien, G Clarke, P Fitzgerald, TG Dinan, BT Griffin, JF Cryan
British journal of pharmacology 166 (4), 1333-1343, 2012
Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies
BT Griffin, CM O’Driscoll
Therapeutic delivery 2 (12), 1633-1653, 2011
Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors
M Bahey-El-Din, PG Casey, BT Griffin, CGM Gahan
Journal of medical microbiology 59 (8), 904-912, 2010
P-glycoprotein inhibition increases the brain distribution and antidepressant-like activity of escitalopram in rodents
FE O'brien, RM O'connor, G Clarke, TG Dinan, BT Griffin, JF Cryan
Neuropsychopharmacology 38 (11), 2209-2219, 2013
Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport
W Faisal, CM O'Driscoll, BT Griffin
Journal of Pharmacy and Pharmacology 62 (3), 323-331, 2010
Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000
M Bahey-El-Din, BT Griffin, CGM Gahan
Microbial Cell Factories 7 (1), 24, 2008
Gut reactions: breaking down xenobiotic–microbiome interactions
G Clarke, KV Sandhu, BT Griffin, TG Dinan, JF Cryan, NP Hyland
Pharmacological reviews 71 (2), 198-224, 2019
The system can't perform the operation now. Try again later.
Articles 1–20